Skip to content

David Agustin Lopez Rodriguez

NPI 1295343267ActiveIndividual· Internal Medicine, Endocrinology, Diabetes & Metabolism· Mayaguez, PR

Internal Medicine, Endocrinology, Diabetes & Metabolism in Mayaguez, Puerto Rico, licensed in PR, with an NPI issued in July 2020. Part D covered 189 prescriptions written in 2024, 58% of them generic. Boehringer Ingelheim Pharmaceuticals, Inc. was the largest of 19 companies reporting payments in 2025, $3,000 in all, mostly food and beverage.

Overview

NPI1295343267
StatusActive
Entity typeIndividual
Sole proprietorNo
NPI issuedJul 16, 2020
Last updated in NPPESJul 1, 2026
Certified by providerJul 1, 2026

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 10, 2026No match—
New York OMIG · Nov 10, 2026No match—
Ohio Medicaid · Nov 10, 2026No match—
Pennsylvania Medicheck · Nov 10, 2026No match—
Washington HCA · Nov 10, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Not in the public enrollment file of Oct 1, 2026

Part D prescriptions in 2024

Prescriptions (claims)189 · 227 30-day fills
Patients25
Total drug cost$76,824
Generic share58% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$3,000 · 73 payments from 19 companies
  • 2024$1,318 · 37 payments from 18 companies

Top paying companies in 2025

What the 2025 payments were for

  • Food and Beverage$3,000 · 73 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Internal Medicine, Endocrinology, Diabetes & Metabolism providers in Mayaguez

All Internal Medicine, Endocrinology, Diabetes & Metabolism providers in Puerto Rico →